AzTrials
AzTrials

Parastomal HerniaCTULOPNCT04311333

Endostomal Three-dimensional Ultrasonography for Parastomal Hernia

A study testing Endostomal three-dimensional ultrasonography, Computerized tomography of the abdomen and Clinical examination in people with Parastomal Hernia, run by Umeå University at 3 sites in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The intention is to examine the role of ultrasonographic examination inside intestinal stomas in diagnosing parastomal hernia. Patients with a stoma since at least one year back who are being scheduled for abdominal surgery will be examined for eligibility according to the selection criteria. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Parastomal Hernia
What is being tested?
Endostomal three-dimensional ultrasonography, Computerized tomography of the abdomen and Clinical examination
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
3 sitesSweden
Study dates
27 Sep 2016to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • End colostomy or end ileostomy since ≥ 1 year
  • Planned for laparotomy or laparoscopy
  • Age ≥ 18
  • Speaks and reads Swedish language
  • Informed consent

Who cannot join

  • Known parastomal hernia only indication for laparotomy or laparoscopy

Trial locations and contacts

3 sites in 1 country.

Johan Nyman, M.D. contact

(+46)90 786 46 87

johan.nyman@umu.se

Karin Strigård, M.D., Ph.D. contact

(+46)90 786 46 87

karin.strigård@umu.se

Sweden3 sites, 3 recruiting
  • Sunderby Hospital

    Luleå, Norrbotten County, 971 80

    Johan Nyman, M.D., +46727436345, johan.nyman@umu.se

    Karin Strigård, M.D., Ph.D., +46907864687, karin.strigard@umu.se

    Recruiting
  • Södertälje Hospital

    Södertälje, Stockholm County, 152 86

    Fredrik Brännström, M.D., Ph.D., +46855024000, fredrikbrannstrom@yahoo.se

    Not yet recruiting
  • University Hospital of Umeå

    Umeå, Västerbotten County, 907 37

    Johan Nyman, M.D., +46727436345, johan.nyman@umu.se

    Karin Strigård, M.D., Ph.D., +46907864687, karin.strigard@umu.se

    Recruiting

Other trials in Sweden

About this study

Official title: Endostomal Three-dimensional Ultrasonography Compared to Clinical Examination, Computerized Tomography and Intraoperative Findings for Parastomal Hernia Diagnosis

The intention is to examine the role of ultrasonographic examination inside intestinal stomas in diagnosing parastomal hernia. Patients with a stoma since at least one year back who are being scheduled for abdominal surgery will be examined for eligibility according to the selection criteria. Included patients will undergo routine clinical examination, endostomal ultrasonography and computerized tomography scan of the abdomen. Findings will be correlated to findings during surgery (gold standard). Values for sensitivity, specificity, predictive values and likelihood ratio will be calculated.

Read the detailed description

Parastomal hernia (PSH) is one of the most common stoma complications, with an incidence of 30-50 % within just a couple of years of stoma creation. Surgical parastomal hernia repair is a morbid and complicated procedure, with a 30-day reoperation rate of 13 % and 30-day mortality rate of 6 % in population-based surveys. There is no established gold standard diagnostic modality. Routinely, patients are examined clinically in various positions with and without increased intra-abdominal pressure. It has been shown in previous studies that clinical examination has a very low inter-observer reliability. Computerized tomography is often performed in addition to clinical examination, but is not ideal in diagnosing PSH either, not only beacause of insufficient test characteristics but also since the examinations should ideally be performed with specific protocols, prone position and be reviewed by a dedicated radiologist. The risk of incorrectly diagnosing a PSH (false positive) is that patients might subsequently be exposed to complex and dangerous surgical interventions without any health benefit, while incorrectly ruling out a PSH (false negative) can cause the patient to have to live with potentially treatable symptoms, life-threatening bowel incarceration being the most severe potential complication.

Thus, improved diagnostic accuracy is required. A method that has been developed within our research group is endostomal tree-dimensional ultrasonography, which has preliminarily proven to be approximately as sensitive as CT, with a markedly higher specificity. A larger and less selected study needs to be conducted in order to reliably calculate test characteristics, predictive values and likelihood ratio.

Being tested
Endostomal three-dimensional ultrasonography, Computerized tomography of the abdomen, Clinical examination, Evaluation at laparotomy/laparoscopy
Keywords
Parastomal hernia, Ultrasound, Ultrasonography, Endostomal, Intrastomal, Colostomy, Ileostomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endostomal three-dimensional ultrasonographyDiagnostic test

    Examination with rectal probe enclosed by water-filled balloon. Rectal mode. Dynamic examination in different positions with and without increased intra-abdominal pressure.

  • Computerized tomography of the abdomenDiagnostic test

    Supine position, without increased intra-abdominal pressure. Experienced radiologist interprets the examination.

    If adequate examination has already been performed within the last 10 months, these images will be used and the patient will thus not undergo computerized tomography within the study.

  • Clinical examinationDiagnostic test

    Patients will be clinically examined with inspection and palpation in supine and erect position with and without increased intra-abdominal pressure.

  • Evaluation at laparotomy/laparoscopyDiagnostic test

    During laparotomy or laparoscopy, inspection and/or palpation of the stoma at the abdominal wall orifice is performed.

Study groups in NCT04311333
Study groupRoleWhat they receive
All patientsExperimentalAll patients undergo endostomal three-dimensional ultrasonography, computerized tomography, clinical examination and laparotomy/laparoscopy. At all the respective examinations, the presence of a parastomal hernia as well as hernia location and size is evaluated.
Receives: Diagnostic Test: Endostomal three-dimensional ultrasonography; Diagnostic Test: Computerized tomography of the abdomen; Diagnostic Test: Clinical examination; Diagnostic Test: Evaluation at laparotomy/laparoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Test characteristics

    Sensitivity, specificity, predictive values, likelihood ratio

    Measured: ≥ 1 year since stoma creation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2020
  2. Study start27 Sep 2016
  3. Primary completion31 Dec 2021 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
All patients will be examined with endostomal three-dimensional ultrasonography, clinical examination and computerized tomography before undergoing laparotomy or laparoscopy
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04311333
Sponsor's protocol ID
CTULOP
Acronym
CTULOP
Status last verified
Nov 2020
First submitted
12 Mar 2020
Last updated
4 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gurmu A, Matthiessen P, Nilsson S, Pahlman L, Rutegard J, Gunnarsson U. The inter-observer reliability is very low at clinical examination of parastomal hernia. Int J Colorectal Dis. 2011 Jan;26(1):89-95. doi: 10.1007/s00384-010-1050-2. Epub 2010 Sep 7.

    PubMed 20821218
  • Gurmu A, Gunnarsson U, Strigard K. Imaging of parastomal hernia using three-dimensional intrastomal ultrasonography. Br J Surg. 2011 Jul;98(7):1026-9. doi: 10.1002/bjs.7505. Epub 2011 Apr 20.

    PubMed 21509751
  • Strigard K, Gurmu A, Nasvall P, Pahlman P, Gunnarsson U. Intrastomal 3D ultrasound; an inter- and intra-observer evaluation. Int J Colorectal Dis. 2013 Jan;28(1):43-7. doi: 10.1007/s00384-012-1526-3. Epub 2012 Jul 7.

    PubMed 22772711
  • Nasvall P, Wikner F, Gunnarsson U, Rutegard J, Strigard K. A comparison between intrastomal 3D ultrasonography, CT scanning and findings at surgery in patients with stomal complaints. Int J Colorectal Dis. 2014 Oct;29(10):1263-6. doi: 10.1007/s00384-014-1944-5. Epub 2014 Jul 2.

    PubMed 24986139

Questions about this trial

What is this clinical trial studying?

A study testing Endostomal three-dimensional ultrasonography, Computerized tomography of the abdomen and Clinical examination in people with Parastomal Hernia, run by Umeå University at 3 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Johan Nyman, M.D. ((+46)90 786 46 87, johan.nyman@umu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Test characteristics (time frame: ≥ 1 year since stoma creation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04311333, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in